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Retroviral replication requires the nuclear export and
cytoplasmic translation of both incompletely spliced and
fully spliced forms of the initial, genome length viral
transcript. Thus in most simple retroviruses, this initial
transcript leaves the nucleus as both an unspliced
mRNA encoding Gag and Gag-Pol and as a singly
spliced mRNA encoding Env. More complex retroviruses
derive a range of unspliced, incompletely spliced and
multiply spliced mRNAs from their single initial RNA
transcript. For example, human immunodeficiency virus
type 1 (HIV-1), which remains the most complex retrovi-
rus known, encodes 1 unspliced ;9-kb RNA encoding
Gag and Gag-Pol, 5 singly spliced, ;4-kb mRNAs en-
coding Vif, Vpr, Vpu, and Env, and finally ;16 multiply
spliced ;2-kb mRNAs encoding Tat, Rev, and Nef.
The ability of retroviruses to express cytoplasmic
mRNAs that retain one or more introns contrasts sharply
with the pattern observed for cellular mRNAs that, while
they may be subject to alternative splicing, are neverthe-
less almost invariably exported from the nucleus in a
fully spliced form. Indeed, nuclear export of RNAs via the
mRNA export pathway is highly selective, so that incom-
pletely spliced RNAs and introns are actively retained in
the nucleus while only fully spliced mRNAs are able to
reach the cytoplasm (Legrain and Rosbash, 1989; Fi-
scher et al., 1994). A subset of splicing factors, termed
commitment factors, are believed to be responsible for
both the nuclear retention of incompletely spliced mR-
NAs and for initial steps in the recognition and definition
of intronic sequences. The rationale for such a nuclear
retention activity is obvious—if it did not exist, the nu-
clear export and cytoplasmic translation of pre-mRNAs
would lead to the synthesis of proteins that were at best
useless and at worst actively deleterious to the welfare
of the eukaryotic cell. Nuclear retention of incompletely
spliced mRNAs is therefore a property observed in all
eukaryotes, from yeast to man.
In the face of this nuclear retention capacity, how is it
that retroviruses are able to efficiently express incom-
pletely spliced mRNAs in infected cells? In fact, it is now
apparent that intron-containing retroviral mRNAs are ex-
ported from the nucleus via export pathways that are at
least in part distinct from the nuclear export pathway
used by fully spliced cellular and retroviral mRNAs. The
study of these alternate nuclear export pathways has led
to considerable insights into retroviral nuclear RNA ex-
port in particular and cellular nucleocytoplasmic trans-
port pathways in general.
HIV-1 Rev is a nuclear RNA export factor
The HIV-1 Rev protein is required for the expression of
the HIV-1 gene products Gag, Gag-Pol, Vif, Env, Vpu, and
Vpr, i.e., the proteins encoded by incompletely spliced
HIV-1 mRNAs, but dispensable for the expression of the
viral proteins encoded by fully spliced mRNAs, i.e., Tat,
Nef, and Rev itself. Because the expression of the former
six proteins requires Rev function, they are expressed
with delayed kinetics in infected cells and are therefore
referred to as late proteins, while Tat, Nef, and Rev are
termed early viral proteins. While this division into early,
regulatory, and late, predominantly structural proteins
echoes the pattern seen in DNA tumor viruses, there is a
critical distinction in that temporal regulation in HIV-1 is
entirely at the posttranscriptional level.
Analysis of HIV-1 RNA expression patterns in trans-
fected cells in the presence and absence of Rev has
revealed that the incompletely spliced 9- and 4-kb
classes of HIV-1 mRNAs are absent from the cytoplasm
in the absence of Rev (Fig. 1A, lane 3) but effectively
expressed in the presence of Rev (lane 4). Simultaneous
analysis of nuclear RNA expression patterns has dem-
onstrated, perhaps surprisingly, that Rev has little or no
effect on the level of nuclear unspliced viral RNA expres-
sion in this system (lanes 1 and 2). In fact, these data
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demonstrate that the initial, genome-length HIV-1 tran-
script is intrinsically inefficiently spliced in primate cells
and that Rev had no further inhibitory effect on this
process. It is now known that HIV-1, like other retrovi-
ruses, contains splice sites that are designed to be
inefficient (Staffa and Cochrane, 1994). Indeed, modifica-
tion of retroviral splice sites so that they are as efficiently
used as are most cellular splice sites results in over-
splicing of retroviral RNAs and renders the virus replica-
tion incompetent (Katz and Skalka, 1990). While ineffi-
cient splicing is therefore critical for retroviral gene ex-
pression, in that it permits the nuclear accumulation of a
pool of incompletely spliced viral RNA, it is not in and of
itself sufficient to permit the cytoplasmic expression of
these RNAs, as can indeed be readily seen by contrast-
ing lanes 1 and 3 in Fig. 1A.
The observation that Rev is able to activate the cyto-
plasmic expression of incompletely spliced HIV-1 mRNA
without further inhibiting the already low efficiency of
HIV-1 RNA splicing (Fig. 1A) led to the proposal that Rev
functioned as a sequence-specific nuclear RNA export
factor (Fig. 1B) (Felber et al., 1989; Hammarskjo¨ld et al.,
1989; Malim et al., 1989b). In this hypothesis, in the
absence of Rev, unspliced (;9 kb) and singly spliced
(;4 kb) HIV-1 RNAs are expressed in the nucleus but are
unable to exit due to nuclear retention by splicing com-
mitment factors. As a result, these RNAs are gradually
spliced to completion and only then exported via the
cellular mRNA export pathway, leading to the synthesis
of Tat, Rev, and Nef (Fig. 1B). Once Rev expression
reaches a critical level (this requires the HIV-1 Tat tran-
scriptional activator), it acts in the nucleus to induce the
sequence-specific nuclear export of the retained incom-
pletely spliced HIV-1 mRNAs (Fig. 1B). Because this de-
pletes the nuclear pool of HIV-1 RNA available for gen-
eration of completely spliced mRNAs, this results in a
drop in the level of cytoplasmic fully spliced HIV-1 mR-
NAs, although the total level of cytoplasmic viral mRNA
remains fairly constant (Fig. 1A, compare lanes 3 and 4).
Subsequent elegant experiments, using microinjection of
synthetic RNAs into the nucleus of Xenopus oocytes,
have fully confirmed the hypothesis that Rev is a se-
quence-specific nuclear RNA export factor (Fischer et al.,
1994).
Although the primary effect of Rev is clearly at the
level of RNA export, Rev can also affect the stability of
incompletely spliced nuclear RNAs in some systems
(Felber et al., 1989; Malim and Cullen, 1993). Specifi-
cally, while incompletely spliced HIV-1 RNAs are quite
stable in the nucleus of transfected fibroblastic cells
FIG. 1. The role of Rev in the HIV-1 life cycle. (A) The level of incompletely spliced (9 1 4 kb class) and fully spliced (2 kb class) HIV-1 RNA
expression in the nucleus (N) and cytoplasm (C) of cells expressing (1) or not expressing (2) the HIV-1 Rev protein was quantified by S1 nuclease
analysis. These RNA samples were derived from transfected COS cells. Modified from Malim et al. (1989b). Reprinted with permission from Nature
(Malim et al. 338, 254–257) Copyright 1989 Macmillan Magazines Limited. (B) Schematic representation of the fate of HIV-1 derived RNA molecules
in the presence and absence of Rev. See text for detailed discussion.
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(e.g., Fig. 1A, lane 1), these RNAs are subject to rela-
tively rapid hydrolysis in some other cell types, includ-
ing T lymphocytes. While the reasons for this differ-
ence are unclear, it has been hypothesized that cellu-
lar commitment factors that induce the nuclear
retention of these viral transcripts may preferentially
target these RNAs for degradation, rather than produc-
tive splicing, in T cells (Malim and Cullen, 1993). Be-
cause the induction of cytoplasmic incompletely
spliced viral RNA expression in T cells largely results
from the nuclear stabilization, and then export, of
these HIV-1 RNAs rather than from their redirection
from productive splicing to nuclear export, Rev has
only a minor inhibitory effect on the level of cytoplas-
mic spliced HIV-1 RNA expression in T cells (Malim
and Cullen, 1993).
Domain organization of HIV-1 Rev
The sequence specificity of Rev function is mediated
by cis-acting viral RNA stem–loop structure, located in
the env gene, termed the Rev response element (RRE)
(Malim et al., 1989b). Rev directly interacts with a specific
loop in the RRE (Fig. 2A) via an arginine-rich RNA binding
motif (ARM) that also serves as the Rev nuclear localiza-
tion signal (NLS) (Fig. 3) (Zapp and Green, 1989; Malim et
al., 1990). While initial binding to the RRE probably in-
volves a Rev monomer, this interaction induces the effi-
cient recruitment of further Rev molecules to the RRE in
a process mediated by two relatively hydrophobic mul-
timerization domains that flank the Rev ARM sequence
(Fig. 3). This process, which results in the formation of a
ribonucleoprotein complex involving the RRE and .10
FIG. 2. Structure of the HIV-1 RRE and MPMV CTE RNA target sites. (A) Proposed structure of the HIV-1 RRE showing the location of the primary
Rev RNA binding site. Modified from Malim et al. (1990). (B) Proposed structure of the MPMV CTE showing the location and approximate extent of
the two identical RNA loops that mediate CTE function. Duplication of the indicated 1/2 CTE permits function in human cells.
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Rev molecules, is clearly critical for Rev function, al-
though the reason why it is essential is not yet under-
stood (Malim and Cullen, 1991; Iwai et al., 1992).
Mutational analysis of Rev revealed that an additional
leucine-rich sequence, located between residues 75 and
84 in the 116 amino acid (aa) Rev protein, was also
critical for Rev function but dispensable for both RRE
binding and Rev multimerization (Fig. 3) (Malim et al.,
1989a; Malim and Cullen, 1991). Therefore, Rev proteins
bearing a mutation of what was initially termed the Rev
‘‘activation domain’’ can compete with wild-type Rev for
binding to the RRE in vivo and exert a potent dominant
negative phenotype, a property that may prove useful in
the design of gene therapy based strategies for the
inhibition of HIV-1 replication in vivo.
If Rev acts as a nuclear RNA export factor and directly
binds to its viral RNA target, Rev would be predicted to
shuttle between the nucleus and cytoplasm of express-
ing cells. Rev shuttling has indeed been directly demon-
strated in experiments that also revealed that the Rev
activation domain is essential for the ability of Rev to
leave the nucleus (Meyer and Malim, 1994). Further ex-
periments revealed that the leucine-rich activation do-
main of Rev is, in fact, a nuclear export signal (NES) that
can induce the efficient nuclear export of linked sub-
strate proteins (Fischer et al., 1995; Wen et al., 1995). As
discussed in more detail below, the Rev NES is the
prototype of a class of leucine-rich NESs, examples of
which have now been observed in a range of other viral
and cellular proteins.
Efforts to isolate a cellular factor that might mediate
Rev NES function led to the identification of a human
gene product that specifically interacted with the Rev
NES in yeast and mammalian forms of the two hybrid
assay (Bogerd et al., 1995; Fritz et al., 1995). This protein,
which was termed either RIP or Rab, was of particular
interest in that it bore the sequence hallmarks of a
nucleoporin, i.e., of a member of the class of proteins that
form the nuclear pore complex, the very structure that
regulates the nuclear import and export of macromole-
cules (reviewed by Mattaj and Englmeier, 1998). When
combined with data showing that overexpression of RIP/
Rab could enhance, albeit modestly, the activity of Rev
when Rev function was limiting or if Rev NES function
was mutationally attenuated, it seemed possible that
RIP/Rab could be a direct target for the Rev NES. Two
findings subsequently shed doubt on this interpretation.
First, it soon became apparent that several other nucleo-
porins could interact with the Rev NES in the two-hybrid
assay with the same specificity noted for RIP/Rab, thus
demonstrating that RIP/Rab was not unique (Stutz et al.,
1995; Fritz and Green, 1996). More importantly, it proved
very difficult to demonstrate a direct interaction in vitro
between purified recombinant Rev and RIP/Rab. These
findings therefore raised the possibility that the Rev:
nucleoporin interaction, while real, was in fact bridged by
a highly conserved protein present in both human and
yeast cells. Recently, it has been demonstrated that this
bridging factor is the conserved nuclear export factor
Crm1 (Fornerod et al., 1997; Neville et al., 1997; Stade et
al., 1997).
Mechanism of action of Rev
Crm1 is a member of a group of related nucleocyto-
plasmic transport factors, of which the prototype is the
Importin b nuclear import factor, that are known to di-
rectly interact with a range of nucleoporins (Mattaj and
Englmeier, 1998). This interaction is required for both
docking at the nuclear pore and probably also for trans-
location through the nuclear pore complex. The biologi-
cal activity of Importin b, Crm1, and related proteins is
regulated by the Ran GTPase and, in particular, by the
GTP-bound form of Ran. RanzGTP is localized to the cell
nucleus due to the cytoplasmic compartmentalization of
the Ran GTPase-activating protein (RanGAP) and the
RanGAP cofactor Ran binding protein 1 (RanBP1). Con-
versely, little RanzGDP exists in the nucleus due to the
nuclear compartmentalization of the Ran-specific gua-
nine nucleotide exchange factor RCC1. RanzGTP binds to
import factors, such as Importin b, in the cell nucleus
and thereby induces the release of import cargo (Mattaj
and Englmeier, 1998). In contrast, binding of RanzGTP to
export factors such as Crm1 is a prerequisite for export
cargo binding in the nucleus (Fornerod et al., 1997).
Overall, the mechanism of action of Rev is therefore
believed to be as follows (Fig. 4). In Step 1, multiple Rev
molecules assemble onto the RRE RNA using the ARM
FIG. 3. Domain organization of HIV-1 Rev. The figure contrasts the
sequence of the Rev NES with that of functionally equivalent NES
sequences found in other viral and cellular proteins. The consensus
NES sequence given at bottom was reported by Bogerd et al. (1996).
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sequence and recruit several RanzGTP-bound Crm1 mol-
ecules to the RRE. In Step 2, Crm1 targets the resultant
ribonucleoprotein complex to the nuclear pore due to a
direct interaction with nucleoporins, presumably includ-
ing RIP/Rab. While translocation through the nuclear
pore is not a well-understood process, it is believed to
involve the sequential interaction of Crm1 with several
specific nucleoporins. Once the complex reaches the
cytoplasm, RanGAP and RanBP1 induce the hydrolysis of
RanzGTP to RanzGDP, thereby inducing the release of
Crm1 from the Rev NES (Step 3, Fig. 4). At this point, the
RRE-containing, incompletely spliced HIV-1 mRNA cargo
is available for translation or, in the case of the unspliced
RNA, virion packaging while both Rev and Crm1 are
recycled back to the nucleus (Step 4).
Evidence has been presented suggesting that the eu-
karyotic cell encodes at least four distinct RNA export
pathways responsible for, respectively, mRNA export,
tRNA export, large ribosomal RNA export, and 5S rRNA
and U-rich small nuclear RNA (U snRNA) export (Mattaj
and Englmeier, 1998). Importantly, the nuclear RNA ex-
port pathway accessed by Rev, and described in Fig. 4,
is distinct from the pathway that mediates the export of
cellular mRNAs. This is of course predicted, in that the
cellular mRNA export pathway is designed to preclude
the export of RNAs that retain introns, i.e., to be unable to
overcome the nuclear retention of such RNAs by com-
mitment factors, while the Rev:Crm1 pathway has no
trouble overcoming such retention. Evidence demon-
strating that the mRNA and Rev RNA export pathways
are distinct was first reported in the Xenopus oocyte
system, where overexpression of the Rev NES was found
to inhibit Rev function as well as 5S rRNA and U snRNA
export but not mRNA export (Fischer et al., 1994). Con-
versely, saturation of the mRNA export pathway blocked
mRNA export but not Rev function or 5S rRNA or U
snRNA export. More recently, the drug leptomycin B,
which is a specific inhibitor of Crm1 function, has been
shown to inhibit Rev function but not mRNA export in
higher eukaryotic cells (Fornerod et al., 1997). Therefore,
it is apparent that the Rev:Crm1 pathway is distinct from
the mRNA export pathway, although Crm1 appears likely
to be important for both 5S rRNA and U snRNA export.
Leucine-rich NESs present in other viral and cellular
proteins
Sequences functionally equivalent to the Rev NES
were first identified in other lentiviruses, such as simian
immunodeficiency virus (SIV) and visna maedi virus
(VMV), based on their ability to substitute for the Rev
activation domain in cis (Fig. 3) (Tiley et al., 1991). An
equivalent sequence, subsequently shown to function as
an NES, was defined using a similar approach in the Rex
nuclear export factor expressed by the unrelated retro-
virus human T cell leukemia virus type I (HTLV-I) (Hope et
al., 1991). More recently, an NES has been identified in
influenza virus NS2, where it has been proposed to play
a critical role in the nuclear export of influenza ribo-
nucleoproteins (O’Neill et al., 1998), and in the ICP27
protein of herpes simplex virus type 1 (HSV-1), where it is
believed to promote the nuclear export of unspliced viral
mRNAs (Sandri-Goldin, 1998). A significant number of
leucine-rich NESs have also been identified in a range of
cellular proteins, including several that have no known
role in RNA export from the nucleus (Fig. 3). It is therefore
apparent that the Crm1 nuclear export pathway is utilized
by a wide range of functionally distinct nucleocytoplas-
mic shuttle proteins. The importance of the Crm1 path-
way for the well-being of the cell, as opposed to the
replication of infecting viruses, is suggested not only by
the remarkable evolutionary conservation of this path-
way but also by the fact that leptomycin B, which is
believed to be a specific inhibitor of Crm1 function, is
cytotoxic in higher eukaryotes.
Inspection of the NES sequences listed in Fig. 3,
when combined with mutational analysis, clearly dem-
onstrates that a primary feature of this sequence is the
presence of four critically spaced large hydrophobic
residues, of which leucine is the most prevalent, in an
otherwise somewhat hydrophilic sequence context.
This impression has been confirmed using a random-
ization/selection protocol in the yeast two hybrid sys-
tem, which led to the proposed NES sequence con-
sensus given at the bottom of Fig. 3, where X can in
principle be any amino acid, although smaller and/or
hydrophilic residues are generally preferred (Bogerd
et al., 1996). It is important to note, however, that
homology to this consensus, while strongly predictive
of NES function when the matching sequence is re-
moved from its normal protein context and attached to
a carrier protein, is not adequate to prove NES func-
tion in situ. Conversely, there are other NES se-
quences, that have no evident homology to the
leucine-rich consensus shown in Fig. 3, that neverthe-
less appear likely to be Crm1 dependent (Bogerd et
al., 1995). It is therefore important to validate any
proposed NES in its normal protein context by show-
ing that it can mediate the nuclear export of that
protein.
Nuclear RNA export in simple retroviruses
The Rev:Crm1 nuclear RNA export pathway appears to
be utilized by all lentiviruses as well as by the family of
complex retroviruses related to HTLV-I, where the Rev
equivalent is termed Rex. However, the various simple
retroviruses are not known to encode an equivalent nu-
clear RNA export factor, and it was therefore initially
unclear how these viruses were able to express an
unspliced form of their genomic RNA in the infected cell
cytoplasm. While this question remains unresolved for
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many retrovirus families, it is now apparent that the type
D simian retroviruses, such as Mason–Pfizer monkey
viruses (MPMV), and avian retroviruses, such as avian
leukemia viruses (ALV), have evolved the ability to di-
rectly recruit cellular nuclear export factors to a struc-
tured sequence present in their genomic RNA transcript
termed the constitutive transport element (CTE).
The MPMV CTE was first identified due to the finding
that a segment of the MPMV genome, located between
the env gene and the 39 long terminal repeat, could
substitute for the RRE and Rev in permitting the nuclear
export of unspliced HIV-1 transcripts (Bray et al., 1994).
Subsequently, it was demonstrated that the CTE was
required for nuclear export and expression of the un-
spliced MPMV genomic, but not of the spliced MPMV
env, mRNA. Interestingly, MPMV genomic RNA expres-
sion could be rescued by substitution of the RRE in place
of the CTE in Rev-expressing cells (Ernst et al., 1997),
thus suggesting that the CTE and Rev:RRE were acting
via a similar mechanism. More recently, it has been
demonstrated that this is not, in fact, the case (Pas-
quinelli et al., 1997; Saavedra et al., 1997). Specifically,
while overexpression of the Rev NES blocked Rev-medi-
ated RNA export in Xenopus oocytes, CTE-dependent
RNA export was unaffected. Conversely, while overex-
pression of the CTE blocked CTE-dependent RNA export,
it failed to affect Rev-mediated RNA export. In addition,
while Rev overexpression, as noted above, inhibits 5S
rRNA and U snRNA, but not mRNA export, CTE overex-
pression inhibits mRNA, but not 5s rRNA and U snRNA
export, from injected Xenopus oocyte nuclei. Overall,
these data suggest that the CTE utilizes export factors
that are, at least in part, shared by the cellular mRNA
nuclear export pathway but apparently irrelevant to the
Rev:Crm1 pathway described above.
Mutational and chemical analysis of the CTE has dem-
onstrated that it folds into an ;138 nucleotide RNA
stem–loop structure containing two identical RNA bulges
that are orientated at 180° relative to one another (Fig.
2B) (Tabernero et al., 1996; Ernst et al., 1997). In mam-
malian cells, CTE function is dependent on the sequence
integrity of both of these loops and the immediately
adjacent stem sequences, as outlined in Fig. 2B. Other
parts of the helical stem appear to serve a structural role,
FIG. 4. Mechanism of action of HIV-1 Rev. The indicated steps in the nucleocytoplasmic shuttling of Rev are defined in the text. The basic domain
of Rev is indicated as both an arginine-rich RNA recognition motif (ARM) and as an NLS sequence, mutually exclusive roles played by this sequence
in, respectively, the nucleus and the cytoplasm.
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while the terminal CTE loop appears unimportant. The
hypothesis that these two identical CTE loops serve as
potentially cooperative binding sites for a cellular factor
is supported by two findings. First, duplication of either
half of the CTE allows CTE function in mammalian cells
in the absence of the other half and, second, for un-
known reasons, the CTE is fully functional with only one
intact loop structure in Xenopus oocytes (Pasquinelli et
al., 1997; Gru¨ter et al., 1998).
While the nuclear export pathway accessed by the
CTE remains to be defined, a strong candidate cofactor,
the human homolog of the yeast nuclear mRNA export
factor Mex67, has recently been reported (Gru¨ter et al.,
1998). Human Mex67 binds the critical duplicate CTE
loops with high specificity in vitro and stimulated CTE-
dependent RNA export when overexpressed in Xenopus
oocytes in vivo. The finding that Mex67 is essential for
mRNA export from the nucleus in yeast cells (Segref et
al., 1997), when combined with the data described above
suggesting that CTE-dependent RNA export and mRNA
export utilize at least some common cofactors, renders
Mex67 a particularly attractive candidate for the CTE
cofactor. While the role of Mex67 in mRNA export in
higher eukaryotes remains to be defined, Mex67 clearly
does not mediate cellular mRNA export by binding to
RNA loops similar to those seen in the CTE. One inter-
esting possibility is that Mex67 is normally recruited at a
late stage in the higher eukaryotic mRNA export path-
way, downstream of the commitment step, by protein:
protein interactions. Direct recruitment of Mex67 by the
CTE may short circuit normally essential earlier steps in
the mRNA export pathway that are blocked when com-
mitment factors remain bound to the RNA, and thereby
allow the nuclear export of an unspliced, CTE containing
transcript (Gru¨ter et al., 1998).
At present, the CTE remains the best-understood RNA
element able to directly access a cellular RNA export
pathway. The ALV CTE, while mutationally defined, has
not been as extensively characterized and has not been
assessed for Mex67 binding (Ogert et al., 1996). Of in-
terest, retroviruses are not the only viruses that contain a
CTE-like element as hepatitis B virus also contains a
cis-acting RNA sequence, termed the posttranscriptional
regulatory element (PRE), that can enhance nuclear RNA
export (Huang and Yen, 1994; Donello et al., 1996). How-
ever, the cellular factors involved in PRE function are
undefined, and it remains unclear if PRE and CTE func-
tion via the same nuclear export pathway. Although cel-
lular equivalents of the MPMV CTE appear very likely to
exist, none have been defined at this point.
Perspective
Research aimed at understanding the role and mech-
anism of action of HIV-1 Rev protein has made a signif-
icant contribution to the remarkable recent progress in
deciphering the regulation of nuclear RNA export in gen-
eral and the role of Crm1 in this pathway in particular. It
seems probable that analysis of MPMV CTE function will
soon lead to additional major insights into the steps
governing the nuclear export of cellular mRNAs, which is
certainly a question of major importance and wide inter-
est. It is therefore apparent that retroviruses have been,
and will continue to be, an important model system for
the definition and functional dissection of the various
nuclear export pathways encoded by their host cells.
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